Antidiabetic Treatments for Diabetes with Liver Cirrhosis
نویسندگان
چکیده
منابع مشابه
Diabetic Complications in Diabetes with Liver Cirrhosis
Received December 14, 2004; revision accepted for publication January 14, 2005. Correspondence: Jo Satoh, Department of Diabetes and Metabolism, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan. e-mail: fufuji@iwate-med. ac.jp, [email protected] Low Incidence of Vascular Complications in Patients with Diabetes Mellitus Associated with Liver Cirrhosis as Compared with Type 2...
متن کاملStatins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
BACKGROUND Type-2 diabetes mellitus (T2DM) is a risk factor for progressive non-alcoholic fatty liver disease (NAFLD). Drugs commonly prescribed in patients with T2DM may affect liver histology by interfering with lipid metabolism and insulin resistance/secretion. AIM We studied if statins or antidiabetic agents were associated with non-alcoholic steatohepatitis (NASH) and significant fibrosi...
متن کاملPyomyositis associated with diabetes mellitus and liver cirrhosis.
Pyomyositis is a primary infection of the skeletal muscle, occurring most commonly in tropical countries. Adults who develop the disease have, in most cases, associated comorbidities that compromise the immune system, including diabetes mellitus and liver cirrhosis.
متن کاملPatients with Liver Cirrhosis
.. Objective: To determine the frequency and severity of hypoglycemia in patients with liver cirrhosis. Study Design: Cross sectional case series study. Period: Six months. Setting: Liaquat University Hospital Hyderabad. Methods: All the patients of liver cirrhosis, of >12 years of age and of either gender were evaluated for hypoglycemia by assessing the glycemic status through random or fastin...
متن کاملRecurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
Non-alcoholic fatty liver disease (NAFLD) is emerging as a major health problem worldwide. NAFLD is a continuum of disease ranging from mild liver steatosis to severe steatohepatitis, which will ultimately lead to end-stage liver disease with high morbidity and mortality rates. This disorder is considered as a silent liver disease. The metabolic syndrome and its components are accounted as the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Interventions in Obesity & Diabetes
سال: 2020
ISSN: 2578-0263
DOI: 10.31031/iod.2020.03.000566